Literature DB >> 12649537

Attenuation of renal ischemia/reperfusion injury by a triple drug combination therapy.

Charanpal S Sekhon1, Bipanjeet K Sekhon, Inderjit Singh, John K Orak, Avtar K Singh.   

Abstract

BACKGROUND: Renal ischemia is of great clinical interest because of its role in renal failure and renal graft rejection. The purpose of this study was to investigate the therapeutic effects of a combination therapy of: n-acetyl cysteine (NAC), a potent antioxidant, sodium nitroprusside (SNP), a nitric oxide donor and phosphormidon (P), an endothelin-1 converting enzyme inhibitor, on tissue protection against renal ischemia/reperfusion injury in the canine model.
METHODS: In this study, 15-20 kg male dogs were subjected to 90 minutes of warm unilateral renal ischemia after removal of one kidney and then divided into control, ischemia alone and treatment groups. Blood samples were collected from these dogs for measurement of kidney function tests and the kidneys were harvested at different time intervals for morphological evaluation, immunostaining and Tunnel Assay.
RESULTS: Kidney function tests (serum creatinine and blood urea nitrogen [BUN]) showed a significant difference between untreated and treated groups. ** P <0.01, * P< 0.0001 for treated versus untreated. The protective effect of the combination therapy is also supported by light microscopic studies, immunostaining of renal tissue sections for pro-inflammatory cytokines (TNF-alpha and IFN-gamma), iNOS, and apoptosis by TUNEL assay.
CONCLUSIONS: Our results suggest that pre-administration of a combination of NAC, SNP, and P attenuates renal ischemia/reperfusion injury. This has potential application in preservation of donor kidney for transplantation by protecting cells against free radical damage.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12649537

Source DB:  PubMed          Journal:  J Nephrol        ISSN: 1121-8428            Impact factor:   3.902


  8 in total

1.  Influence of ascorbic acid on BUN, creatinine, resistive index in canine renal ischemia-reperfusion injury.

Authors:  Jae-il Lee; Myung-jin Kim; Chang-sik Park; Myung-cheol Kim
Journal:  J Vet Sci       Date:  2006-03       Impact factor: 1.672

2.  Investigation of the role of nitric oxide/soluble guanylyl cyclase pathway in ascorbic acid-mediated protection against acute kidney injury in rats.

Authors:  Vaishali Koul; Anudeep Kaur; Amrit Pal Singh
Journal:  Mol Cell Biochem       Date:  2015-07-05       Impact factor: 3.396

Review 3.  Novel pharmacological approaches to the treatment of renal ischemia-reperfusion injury: a comprehensive review.

Authors:  Prabal K Chatterjee
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-09-22       Impact factor: 3.000

4.  Effect of a combined treatment with erythropoietin and melatonin on renal ischemia reperfusion injury in male rats.

Authors:  Nasser Ahmadiasl; Shokofeh Banaei; Alireza Alihemati; Behzad Baradaran; Ehsan Azimian
Journal:  Clin Exp Nephrol       Date:  2014-02-04       Impact factor: 2.801

5.  Attenuation of ischemia-reperfusion injury by ascorbic acid in the canine renal transplantation.

Authors:  Jae-il Lee; Hwa-Young Son; Myung-cheol Kim
Journal:  J Vet Sci       Date:  2006-12       Impact factor: 1.672

6.  Combination antioxidant effect of erythropoietin and melatonin on renal ischemia-reperfusion injury in rats.

Authors:  Nasser Ahmadiasl; Shokofeh Banaei; Alireza Alihemmati
Journal:  Iran J Basic Med Sci       Date:  2013-12       Impact factor: 2.699

7.  The effect of 5-aminosalicylic acid on renal ischemia-reperfusion injury in rats.

Authors:  Shokofeh Banaei
Journal:  Indian J Pharmacol       Date:  2016 Mar-Apr       Impact factor: 1.200

Review 8.  Large animal models for translational research in acute kidney injury.

Authors:  Balamurugan Packialakshmi; Ian J Stewart; David M Burmeister; Kevin K Chung; Xiaoming Zhou
Journal:  Ren Fail       Date:  2020-11       Impact factor: 2.606

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.